The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer
Open accessAbstract
Gastric cancer (GC) represents a significant burden of cancer-related mortality worldwide, underscoring an urgent need for the development of early detection strategies and precise postoperative interventions. However, the identification of non-invasive biomarkers for early diagnosis and patient risk stratification remains underexplored. Here, we conduct a targeted metabolomics analysis of 702 plasma samples from multi-center participants to elucidate the GC metabolic reprogramming. Our machine learning analysis reveals a 10-metabolite GC diagnostic model, which is validated in an external test set with a sensitivity of 0.905, outperforming conventional methods leveraging cancer protein markers (sensitivity < 0.40). Additionally, our machine learning-derived prognostic model demonstrates superior performance to traditional models utilizing clinical parameters and effectively stratifies patients into different risk groups to guide precision interventions. Collectively, our findings reveal the metabolic landscape of GC and identify two distinct biomarker panels that enable early detection and prognosis prediction respectively, thus facilitating precision medicine in GC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Patients who are distinguished by the 28-PM model from the high-risk group are more likely to reveal worse survival compared with the low-risk group and provide an advantage from intensive monitoring, intervention, and clinical trial.”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [62]
The cited source says what the claim attributes to it.
In the citing paper
“Machine learning-derived 28-metabolite prognostic model showed successful predictive activity with an AUROC of 0.832 and a concordance index of 0.83.”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [62]
The cited source says what the claim attributes to it.
In the citing paper
“Among them, 11 of the 28 metabolites (symmetric dimethylarginine/asymmetric dimethylarginine, neopterin, thymine, glucuronate, hydroxyproline, 14:0 Carnitine, indole acrylate, 8:0 Carnitine, acetylalanine, 2-aminoadipate, and GlcNAc6p) significantly discriminated the prognosis of GC patients.”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Regression shrinkage and selection via the lasso
Tibshirani, R. (1996) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1996.tb02080.x · Cited by 51,482
Smyth, E. C., Nilsson, M., Grabsch, H. I., van Grieken, N. C., & Lordick, F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31288-5 · Cited by 4,803
Applications of machine learning in drug discovery and development
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0024-5 · Cited by 3,228
Ishwaran, H., Kogalur, U. B., Blackstone, E. H., & Lauer, M. S. (2008) · The Annals of Applied Statistics · doi:10.1214/08-aoas169 · Cited by 2,714
Understanding the Intersections between Metabolism and Cancer Biology
Vander Heiden, M. G., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,293
A guide to machine learning for biologists
Greener, J. G., Kandathil, S. M., Moffat, L., & Jones, D. T. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00407-0 · Cited by 2,127
Biomarkers in Cancer Staging, Prognosis and Treatment Selection
Ludwig, J. A., & Weinstein, J. N. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1739 · Cited by 1,666
Thrift, A. P., & El-Serag, H. B. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.045 · Cited by 1,456
Cited by
Matsuoka, T., & Yashiro, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115880 · Cited by 83
“A more recent study that employed LC–MS-based targeted metabolomics to illustrate the global metabolomic profiling of large cohorts analyzed plasma samples from GC patients utilizing machine learning [62].”
Method
Metadata
- Authors
- Chen, Y., Wang, B., Zhao, Y., Shao, X., Wang, M., Ma, F., Yang, L., Nie, M., Jin, P., Yao, K., Song, H., Lou, S., Wang, H., Yang, T., Tian, Y., Han, P., & Hu, Z.
- Affiliations
- Tsinghua University (CN)
- Center for Life Sciences (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Harbin Medical University (CN)
- Fudan University (CN)
- Corresponding author
- Tian, Yantao
- Han, Peng
- Hu, Zeping
- ORCID
- Venue
- Nature Communications
- Published
- 2024-02-23
- Volume
- 15
- Issue
- 1
- Pages
- 1657-1657
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC10891053
- OpenAlex
- W4392125974
- Cited by
- 244
- References
- 80
- Citations by year
- 2026: 102 · 2025: 108 · 2024: 34
- FWCI
- 32.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Harbin Medical University
- National Natural Science Foundation of China (92057209, 82072640, 81973355)
- Chinese Academy of Medical Sciences
- Peking Union Medical College
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Physical Sciences › Engineering › Biomedical Engineering › Advanced Chemical Sensor Technologies
- Keywords
- gastric cancer, plasma metabolomics, targeted metabolomics, non-invasive biomarkers, early diagnosis, prognostic model, risk stratification, metabolic reprogramming, machine learning prediction models, precision medicine
- MeSH terms
- Machine Learning, Metabolic Reprogramming, Humans, Stomach Neoplasms, Metabolomics, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer. https://app.cochat.ai/papers/10.1038/s41467-024-46043-y
- The paper
- Chen, Y., Wang, B., Zhao, Y., Shao, X., Wang, M., Ma, F., Yang, L., Nie, M., Jin, P., Yao, K., Song, H., Lou, S., Wang, H., Yang, T., Tian, Y., Han, P., & Hu, Z. (2024). Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer. Nature Communications. https://doi.org/10.1038/s41467-024-46043-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.